cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum

Go back to cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
(NYSE: YCBD) Delayed: 0.69 -0.03 (4.17%)
Previous Close $0.72    52 Week High
Open $0.70    52 Week Low
Day High $0.72    P/E N/A 
Day Low $0.69    EPS
Volume 55,627       

(NYSE: YCBD) Delayed: 0.69 -0.03 (4.17%)
Previous Close $0.72    52 Week High
Open $0.70    52 Week Low
Day High $0.72    P/E N/A 
Day Low $0.69    EPS
Volume 55,627